Authorised KMPs to determine materiality of events/information
Alkem Laboratories Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information".12-02-2016
12-02-2016
Financial Results, Limited Review Report for December 31, 2015
Alkem Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Consolidated Financial Results for the period ended December 31, 20153. Standalone Limited Review for the period ended December 31, 20154. Consolidated Limited Review for the period ended December 31, 201512-02-2016
Intimation of Conference call
Alkem Laboratories Ltd has informed BSE regarding "Intimation of Conference call on Q3FY16 results".03-02-2016
Shareholding for the Period Ended December 31, 2015
Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here03-02-2016
Alkem stock jumps over 4% on Nomura rating
Shares of pharmaceutical company Alkem Laboratories today jumped as Nomura has given buy rating. The stock gained as much as 4.2 per cent as Nomura has rated the companys stock as buy with a ...02-02-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Alkem Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.19-01-2016
Plan to Launch 5-10 Products in US Over Two Years: Alkem Lab
Alkem Laboratories' debut in stock markets has been nothing short of phenomenal, with its shares gaining 47 per cent in two trading sessions.25-12-2015
Code of Conduct of Fair Disclosure
Alkem Laboratories Ltd has informed BSE about formulation and adoption of Codes under SEBI (Prohibition of Insider Trading) Regulations, 2015.25-12-2015
Alkem, Dr Lal IPOs spark off Rs 30,000 cr of broker loans
Listings help revive demand at NBFC arms of brokerages24-12-2015
Closure of Trading Window
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company in their meeting held on November 20, 2015 approved the Code of Practices and Procedures for Fair Disclosure of Un-Published Price Sensitive Information and Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders ("Insider Trading Code")....24-12-2015